Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Clinical trial NCT01482728 · COMPLETED
Trial details
- NCT number
- NCT01482728
- Sponsor
- University of Virginia
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.